Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Neurological Research and Practice
|
August 28, 2025
Optical coherence tomography - A possible biomarker in early huntington's disease
Clancy Cerejo, Elias Mandler, Federico Carbone, et al.
Journal of Parkinson'S Disease
|
April 3, 2023
Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson's Disease
Marina Peball, Dora Valent, Anna Grossauer, et al.
Movement Disorders Clinical Practice
|
April 27, 2026
Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical Practice
Frank Jagusch, Elena Redl, Christoph Theyer, et al.
Biology of Sex Differences
|
April 3, 2026
Sex-related differences in Huntington's disease: a scoping review
Greta Hemicker, Katarína Schwarzová, Clancy Cerejo, et al.
Movement Disorders Clinical Practice
|
August 8, 2022
Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post-hoc Analysis of NMS-Nab Study
Marina Peball, Klaus Seppi, Florian Krismer, et al.
Neurology International
|
January 24, 2025
Optical Coherence Tomography in Huntington's Disease-A Potential Future Biomarker for Neurodegeneration?
Clancy Cerejo, Nicolas De Cleene, Elias Mandler, et al.
Clinical Therapeutics
|
May 29, 2026
Long-Term Use of Tiapride and Tetrabenazine in Huntington's Disease: A 25-Year Retrospective Single-Center Analysis
Katarína Schwarzová, Samuel Labrecque, Greta Hemicker, et al.
Brain Sciences
|
May 28, 2022
Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
Philipp Ellmerer, Marina Peball, Federico Carbone, et al.
Journal of Neurology
|
February 1, 2025
Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington's disease
Beatrice Heim, Elias Mandler, Marina Peball, et al.
Movement Disorders Clinical Practice
|
February 11, 2026
Resolution of Levodopa/Dopa-Decarboxylase Inhibitor-Associated Microscopic Colitis with Subcutaneous Foslevodopa/Foscarbidopa: A Case Series and Review of the Literature
Romana Hintner, Franziska Eberhardt, Manuela Kofler, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Neurological Research and Practice
|
August 28, 2025
Optical coherence tomography - A possible biomarker in early huntington's disease
Clancy Cerejo, Elias Mandler, Federico Carbone, et al.
Journal of Parkinson'S Disease
|
April 3, 2023
Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson's Disease
Marina Peball, Dora Valent, Anna Grossauer, et al.
Movement Disorders Clinical Practice
|
April 27, 2026
Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical Practice
Frank Jagusch, Elena Redl, Christoph Theyer, et al.
Biology of Sex Differences
|
April 3, 2026
Sex-related differences in Huntington's disease: a scoping review
Greta Hemicker, Katarína Schwarzová, Clancy Cerejo, et al.
Movement Disorders Clinical Practice
|
August 8, 2022
Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post-hoc Analysis of NMS-Nab Study
Marina Peball, Klaus Seppi, Florian Krismer, et al.
Neurology International
|
January 24, 2025
Optical Coherence Tomography in Huntington's Disease-A Potential Future Biomarker for Neurodegeneration?
Clancy Cerejo, Nicolas De Cleene, Elias Mandler, et al.
Clinical Therapeutics
|
May 29, 2026
Long-Term Use of Tiapride and Tetrabenazine in Huntington's Disease: A 25-Year Retrospective Single-Center Analysis
Katarína Schwarzová, Samuel Labrecque, Greta Hemicker, et al.
Brain Sciences
|
May 28, 2022
Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
Philipp Ellmerer, Marina Peball, Federico Carbone, et al.
Journal of Neurology
|
February 1, 2025
Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington's disease
Beatrice Heim, Elias Mandler, Marina Peball, et al.
Movement Disorders Clinical Practice
|
February 11, 2026
Resolution of Levodopa/Dopa-Decarboxylase Inhibitor-Associated Microscopic Colitis with Subcutaneous Foslevodopa/Foscarbidopa: A Case Series and Review of the Literature
Romana Hintner, Franziska Eberhardt, Manuela Kofler, et al.
Page
of 8